Viewing Study NCT07344818


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-30 @ 12:12 AM
Study NCT ID: NCT07344818
Status: RECRUITING
Last Update Posted: 2026-01-15
First Post: 2026-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
Sponsor: Peking University People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module